2100-2101 / 2351
Protocol-specified criteria for success were:
HR
≤0.67 and posterior probability of (HR <1) >97.5%
BERIL-1 Primary Endpoint: Progression-free Survival
June 5,
2016
CI, confidence interval.
*The 97.5% Bayesian posterior probability criteria is equivalent to a 95% CI being <1;
†
Nominal p-value, not adjusted for multiple testing.
6-month PFS rate:
34%
vs
19%
Soulières D
et al.
ASCO
2016:Abstract 6008